Fig. 1From: Dose-response to inhaled glycopyrrolate delivered with a novel Co-Suspension™ Delivery Technology metered dose inhaler (MDI) in patients with moderate-to-severe COPDStudy design schematic. Rand Randomization; PFT Pulmonary Function Test; Rx TreatmentBack to article page